An investigation on behalf of investors in Zafgen Inc (NASDAQ: ZFGN) shares over potential wrongdoing at Zafgen Inc (NASDAQ: ZFGN) was announced and NASDAQ: ZFGN stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 10/09/2019 -- An investigation was announced for investors in shares of Zafgen Inc (NASDAQ: ZFGN) concerning potential breaches of fiduciary duties by certain directors at Zafgen Inc.
Investors who purchased shares of Zafgen Inc (NASDAQ: ZFGN) have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Zafgen Inc directors breached their fiduciary duties and caused damage to the company and its shareholders.
Boston, MA based Zafgen, Inc., a clinical-stage biopharmaceutical company, develops therapies for patients suffering from metabolic diseases comprising type 2 diabetes, Prader-Willi syndrome (PWS), and liver diseases. On March 11, 2019, Zafgen Inc announced its decision to suspend plans to file an investigational new drug application forZGN-1258,the Company's candidate for rare metabolic disorders based on a finding in rodent toxicology studies. According to Zafgen Inc, data showed degeneration and other anomalies in rat muscle tissue to different degrees in both vehicle and dose arms of the studies.
Those who purchased shares of Zafgen Inc (NASDAQ: ZFGN) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels